Cleo Robinson

A Novel SV40 TAg Transgenic Model of Asbestos-Induced Mesothelioma: Malignant Transformation Is Dose Dependent

Cleo Robinson, Ivonne van Bruggen, Amanda Segal et al. · Cancer Research · 2006 · 84 citations · Full text

Medicine, Genetics, Oncology +12

Circulating Tumor DNA Predicts Outcome from First-, but not Second-line Treatment and Identifies Melanoma Patients Who May Benefit from Combination Immunotherapy

Gabriela Marsavela, Jenny Lee, Leslie Calapre et al. · Clinical Cancer Research · 2020 · 63 citations · Full text

Medicine, Clinical Sciences, Oncology +17

Sensitive droplet digital PCR method for detection of<i>TERT</i>promoter mutations in cell free DNA from patients with metastatic melanoma

Ashleigh C. McEvoy, Leslie Calapre, Michelle R. Pereira et al. · Oncotarget · 2017 · 56 citations · Full text

Medicine, Molecular Biology, Oncology +17

A genome-wide association study for malignant mesothelioma risk

Gemma Cadby, Sutapa Mukherjee, Arthur W. Musk et al. · Lung Cancer · 2013 · 51 citations · Full text

Life Sciences, Genetics, Oncology +11

Locus‐specific concordance of genomic alterations between tissue and plasma circulating tumor<scp>DNA</scp>in metastatic melanoma

Leslie Calapre, Tindaro Giardina, Cleo Robinson et al. · Molecular Oncology · 2018 · 47 citations · Full text

Medicine, Genetics, Molecular Genetics +17